Table 1.
FGFR2/3 fusion subtype prevalence and distribution across different histological non-small cell lung cancer subtypes in the Guardant Health electronic database.
| FGFR Fusion Type | Large-Cell Carcinoma | ADC | Adeno-Squamous Carcinoma | SCC | NSCLC NOS Carcinoma |
Total |
|---|---|---|---|---|---|---|
| FGFR2-BICC1 | 4 | 4 | ||||
| FGFR2-CCDC6 | 1 | 1 | ||||
| FGFR2-KIAA1598 | 3 | 1 | 4 | |||
| FGFR2-SLC45A3 | 1 | 1 | ||||
| FGFR2-TACC2 | 2 | 1 | 3 | |||
| FGFR3-TACC3 | 4 | 71 | 1 | 61 | 13 | 150 |
| FGFR3-WHSC1 | 1 | 1 | ||||
| Total | 4 | 81 | 1 | 62 | 16 | 164 |
Abbreviations: ADC—adenocarcinoma; FGFR—fibroblast growth factor receptor; NSCLC NOS—non-small cell lung cancer non otherwise specified carcinoma; SCC—squamous cell carcinoma.